Glenmark Life Sciences
₹820.00
-7.75 (-0.94%)
13 May, 2024 14:40 BSE: 543322
NSE: GLSISIN: INE03Q201024
Start SIP in Glenmark Life Sciences
Start SIPGlenmark Life Sciences Performance
Day Range
- Low 812
- High 832
52 Week Range
- Low 513
- High 906
- Open Price832
- Previous Close828
- Volume44950
Glenmark Life Sciences Financials
Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|
Oper Rev Qtr Cr | 537 | 573 | 595 | 578 | 621 |
Operating Expenses Qtr Cr | 395 | 400 | 428 | 385 | 415 |
Operating Profit Qtr Cr | 141 | 173 | 167 | 193 | 206 |
Depreciation Qtr Cr | 15 | 13 | 13 | 13 | 12 |
Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 |
Tax Qtr Cr | 32 | 42 | 40 | 47 | 51 |
Net Profit Qtr Cr | 98 | 119 | 119 | 135 | 146 |
Glenmark Life Sciences Technicals
EMA & SMA
Current Price
₹820.00
-7.75 (-0.94%)
- Bullish Moving Average
- ___
- 8
- Bearish Moving Average
- ___
- 8
- 20 Day
- ₹819.07
- 50 Day
- ₹805.07
- 100 Day
- ₹776.20
- 200 Day
- ₹715.58
- 20 Day
- ₹817.97
- 50 Day
- ₹798.83
- 100 Day
- ₹786.56
- 200 Day
- ₹709.16
Glenmark Life Sciences Resistance and Support
PIVOT
₹830.1
Resistance | |
---|---|
First Resistance | 836.65 |
Second Resistance | 845.55 |
Third Resistance | 852.10 |
RSI | 53.74 |
MFI | 59.74 |
MACD Single Line | 9.17 |
MACD | 10.19 |
Support | |
---|---|
First Resistance | 821.20 |
Second Resistance | 814.65 |
Third Resistance | 805.75 |
Glenmark Life Sciences Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 42,244 | 2,882,731 | 68.24 |
Week | 75,350 | 4,192,452 | 55.64 |
1 Month | 153,334 | 7,096,293 | 46.28 |
6 Month | 178,917 | 10,686,725 | 59.73 |
Glenmark Life Sciences Result Highlights
Glenmark Life Sciences Synopsis
NSE-Medical-Ethical Drugs
Glenmark Life Scienc is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 2283.21 Cr. and Equity Capital is Rs. 24.51 Cr. for the Year ended 31/03/2024. Glenmark Life Sciences Ltd. is a Public Limited Listed company incorporated on 23/06/2011 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L74900PN2011PLC139963 and registration number is 139963.Market Cap | 9,992 |
Sales | 2,283 |
Shares in Float | 2.08 |
No of funds | 88 |
Yield | 2.76 |
Book Value | 4.35 |
U/D Vol ratio | 1.1 |
LTDebt / Equity | |
Alpha | 0.13 |
Beta | 0.84 |
Glenmark Life Sciences
Owner Name | Mar-24 | Dec-23 | Sep-23 | Jun-23 |
---|---|---|---|---|
Promoters | 82.85% | 82.85% | 82.85% | 82.85% |
Mutual Funds | 0.93% | 0.59% | 0.38% | 0.52% |
Insurance Companies | 0.15% | |||
Foreign Portfolio Investors | 5.01% | 4.57% | 4.39% | 3.27% |
Financial Institutions/ Banks | ||||
Individual Investors | 9.09% | 9.2% | 9.21% | 10.02% |
Others | 2.12% | 2.79% | 3.02% | 3.34% |
Glenmark Life Sciences Management
Name | Designation |
---|---|
Mr. Glenn Saldanha | Chairman & Non-Exe.Director |
Dr. Yasir Rawjee | Managing Director & CEO |
Mr. Vinod Naik | Executive Director |
Mr. V S Mani | Non Executive Director |
Mr. Sridhar Gorthi | Independent Director |
Mrs. Manju Agarwal | Independent Director |
Mr. Taruvai Laxminarayanan Easwar | Independent Director |
Ms. Gita Nayyar | Independent Director |
Glenmark Life Sciences Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Glenmark Life Sciences Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-04-25 | Audited Results | |
2024-01-23 | Quarterly Results | |
2023-10-20 | Quarterly Results | |
2023-10-09 | Interim Dividend | |
2023-07-21 | Quarterly Results |
Date | Purpose | Remarks |
---|---|---|
2023-10-17 | INTERIM | Rs.22.50 per share(1125%)Interim Dividend |
2023-03-24 | INTERIM | Rs.21.00 per share(1050%)Interim Dividend |
2021-11-23 | INTERIM | Rs.10.50 per share(525%)Interim Dividend |
Glenmark Life Sciences FAQs
What is Share Price of Glenmark Life Sciences ?
Glenmark Life Sciences share price is ₹820 As on 13 May, 2024 | 14:26
What is the Market Cap of Glenmark Life Sciences ?
The Market Cap of Glenmark Life Sciences is ₹10047.2 Cr As on 13 May, 2024 | 14:26
What is the P/E ratio of Glenmark Life Sciences ?
The P/E ratio of Glenmark Life Sciences is 21.3 As on 13 May, 2024 | 14:26
What is the PB ratio of Glenmark Life Sciences ?
The PB ratio of Glenmark Life Sciences is 4.3 As on 13 May, 2024 | 14:26